Active Motif to Distribute Arima Genomics' 3D Genomics Solutions Globally
Active Motif has announced an exclusive global distribution agreement with Arima Genomics for advanced 3D genomics solutions. The partnership expands Active Motif's research genomics portfolio.
Carlsbad, Calif. – July 6, 2026 – Active Motif has entered into an exclusive global distribution agreement with Arima Genomics, Inc. The partnership will see Active Motif distribute Arima Genomics' advanced 3D genomics solutions worldwide.
This agreement is expected to enhance Active Motif's offerings in the field of research genomics, complementing its existing portfolio in epigenetics and multiomics. For Arima Genomics, the agreement supports its strategic focus on advancing its clinical diagnostics platform.
3D genomics technology provides researchers with enhanced insights into genome architecture and its role in gene regulation and cellular function. By leveraging Active Motif's established distribution channels, Arima Genomics' solutions will become more accessible to the global scientific community.
The collaboration aims to accelerate research by providing scientists with comprehensive tools for studying complex genomic interactions. Financial terms of the agreement have not been disclosed by either company.